Cell entry of lymphocytic choriomeningitis virus is restricted in myotubes

Masaharu Iwasaki1, Shuzo Urata1, Yoshitake Cho2

  • 1Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA.

Virology
|June 15, 2014
PubMed

Insights

Skeletal muscle cells resist lymphocytic choriomeningitis virus (LCMV) infection after differentiation. This resistance is due to impaired viral entry, not intracellular factors, explaining LCMV absence in carrier mice.

Area of Science:

  • Virology
  • Immunology
  • Cell Biology

Background:

  • Persistent lymphocytic choriomeningitis virus (LCMV) infection in mice typically shows viral presence in most organs.
  • Skeletal muscle, however, remarkably lacks detectable viral antigen and RNA in LCMV-carrier mice.

Purpose of the Study:

  • To investigate the mechanism behind the absence of LCMV in skeletal muscle of persistently infected mice.
  • To determine why differentiated muscle cells (myotubes) are resistant to LCMV infection.

Main Methods:

  • Infection of mouse C2C12 myoblasts and differentiated myotubes with LCMV.
  • Analysis of viral replication and entry.
  • Assessment of LCMV receptor (alpha-dystroglycan) expression.

Main Results:

  • Differentiated C2C12 myotubes become highly refractory to LCMV infection compared to myoblasts.
  • Myotube resistance is mediated by impaired viral entry, specifically involving the LCMV surface glycoprotein.
  • This resistance occurs despite high expression of the LCMV receptor, alpha-dystroglycan, on myotubes.

Conclusions:

  • LCMV entry into differentiated skeletal muscle cells is significantly restricted.
  • Impaired viral entry, not intracellular replication blockade, explains LCMV absence in mouse skeletal muscle.
  • Findings elucidate a key aspect of viral persistence and tissue tropism in arenavirus infections.